SEC Filings

Filing date Description Form Filing Group Issuer View

DEF 14C

DEF 14C
Other
Urovant Sciences Ltd. View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Urovant Sciences Ltd. View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Urovant Sciences Ltd. View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
3,4,5
Urovant Sciences Ltd. View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
Urovant Sciences Ltd. View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Urovant Sciences Ltd. View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
Urovant Sciences Ltd. View HTML

A preliminary proxy statement containing all other information

PRE 14C
Proxy Filings
Urovant Sciences Ltd. View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Urovant Sciences Ltd. View HTML

EFFECT

EFFECT
Other
Urovant Sciences Ltd. View HTML

Copyright Morningstar